Assetmark »

TherapeuticsMD shares owned by Assetmark

Quarter-by-quarter ownership of TherapeuticsMD (TXMD) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in TherapeuticsMD

Tip: Access up to 7 years of quarterly data

All positions including TherapeuticsMD held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in TherapeuticsMD by Assetmark

Quarter filed Position value Share count Share price at filing
2024-09-30 $7 4 1.75
2024-03-31 $2 1 2.00

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Ishares Tr Core S&p500 Etf (IVV)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Core Msci Emkt (IEMG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)

View all positions for Assetmark

Top funds holding TherapeuticsMD

Rubric Capital Management
Clearline Capital
Tejara Capital
Vanguard Group
Morgan Stanley
BlackRock
BlackRock
Geode Capital Management
Bridgeway Capital Management
State Street Corporation
Northern Trust
Two Sigma Securities
J. Goldman & Co
Citadel Advisors
Tower Research Capital

View all funds holding TherapeuticsMD